| Jillian Picarillo, DPT | |
|
86 Main Ave, Wynantskill, NY 12198-7541 | |
| (518) 326-0702 | |
| (518) 326-0706 |
| Full Name | Jillian Picarillo |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 86 Main Ave, Wynantskill, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275310567 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 050684-01 (New York) | Primary |
| Provider Name | Nje Pt Movement Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1750775995 PECOS PAC ID: 9739408295 Enrollment ID: O20150811004375 |
News Archive
Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., announced today that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for KYNAMRO (mipomersen sodium) for the treatment of patients with homozygous familial hypercholesterolemia (HoFH).
LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences startups, announced that Life Technologies will provide an innovative technology suite of instruments representing the latest platforms developed by the company under an agreement inked last month.
A 2013 study by Pérez et al. reported a very high accumulation of the industrial chemical perfluorobutanoic acid (PFBA) in human lungs and kidneys. The German Federal Institute for Risk Assessment (BfR) checked these results using a more precise quantification method. The result: Only one sample contained a quantifiable PFBA value of 0.17 nanograms (ng) per gram (g) of lung tissue.
With increasing numbers of men and women serving in combat and risking traumatic injury and limb loss, a new study published in The Journal of Pain, the peer-reviewed publication of the American Pain Society, concludes that self-reported amputation-specific pain severity is similar in men and women but there are considerable gender variations in overall pain outcomes, such as emotional health and pain-coping responses.
A team of researchers at CNRS, Aix-Marseille Université and Université Paris 13 has demonstrated effective molecular labeling to unequivocally identify biomedical implants, even after a prolonged period inside the living being. These results were published in Angewandte Chemie International Edition on July 5, 2018.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jillian Picarillo, DPT 506 Campbell Ave, Troy, NY 12180-6243 Ph: (518) 203-6761 | Jillian Picarillo, DPT 86 Main Ave, Wynantskill, NY 12198-7541 Ph: (518) 326-0702 |
News Archive
Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., announced today that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for KYNAMRO (mipomersen sodium) for the treatment of patients with homozygous familial hypercholesterolemia (HoFH).
LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences startups, announced that Life Technologies will provide an innovative technology suite of instruments representing the latest platforms developed by the company under an agreement inked last month.
A 2013 study by Pérez et al. reported a very high accumulation of the industrial chemical perfluorobutanoic acid (PFBA) in human lungs and kidneys. The German Federal Institute for Risk Assessment (BfR) checked these results using a more precise quantification method. The result: Only one sample contained a quantifiable PFBA value of 0.17 nanograms (ng) per gram (g) of lung tissue.
With increasing numbers of men and women serving in combat and risking traumatic injury and limb loss, a new study published in The Journal of Pain, the peer-reviewed publication of the American Pain Society, concludes that self-reported amputation-specific pain severity is similar in men and women but there are considerable gender variations in overall pain outcomes, such as emotional health and pain-coping responses.
A team of researchers at CNRS, Aix-Marseille Université and Université Paris 13 has demonstrated effective molecular labeling to unequivocally identify biomedical implants, even after a prolonged period inside the living being. These results were published in Angewandte Chemie International Edition on July 5, 2018.
› Verified 4 days ago
Mr. Rodd Koch, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 32 Francis Dr, Wynantskill, NY 12198 Phone: 518-286-9021 | |
Maureen O'brien, Physical Therapist Medicare: Medicare Enrolled Practice Location: 15 Ridgewood Dr, Wynantskill, NY 12198 Phone: 518-674-1744 |